This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
HBSP (USA)
-
Zebra Medical Vision (Spanish version)
Greenstein, Shane; Gulick, SarahCase HBS-620S05EntrepreneurshipWhat should they do next at Zebra? Should they work on the accuracy of the already-developed algorithms, or continue to develop many new tools? If they chose to develop new products, which applications should they address? And how should they go to market?Starting at €8.20
-
How to Jump-Start the Clean-Tech Economy
Johnson, Mark W.; Suskewicz, JoshArticle HBS-R0911D-EStrategyBillions of dollars worldwide are pumped into the search for clean technology and renewable energy. So far, however, most investment has been in companies that are using conventional business models to fit new technologies into existing systems. A far better approach, say Johnson and Suskewicz, is to create whole new systems. The authors propose a framework for thinking about clean tech that consists of four interdependent components: an enabling...Starting at €8.20
-
Israel at 70: Is it Possible to (re)Brand a Country
Ofek, Elie; Gulick, SarahCase HBS-519006-EMarketingIn the spring of 2018, Israel was set to celebrate its 70th anniversary. While there was much to rejoice in reaching this milestone, the country's brand image internationally was far from ideal. Past efforts to impact perceptions of Israel, spearheaded by the Ministry of Foreign Affairs as well as various Jewish organizations, were mainly aimed at "explaining" Israel's political position and convincing the world that the country was acting in a j...Starting at €8.20
-
DayTwo: Going to Market with Gut Microbiome
Israeli, Ayelet; Lane, DavidCase HBS-519010-EMarketingDayTwo is a young Israeli startup that applies research on the gut microbiome and machine learning algorithms to deliver personalized nutritional recommendations to its users in order to minimize blood sugar spikes after meals. After a first year of trial rollout in Israel, CEO Lihi Segal and her team are devising a global go-to-market plan for the firm. The team is considering several target markets, ranging from people with diabetes to professi...Starting at €8.20
-
Israel at 70: Is it Possible to (re)Brand a Country, Teaching Note
Ofek, ElieTeaching Note HBS-519081-EMarketingTeaching note for case 519006.Starting at €0.00
-
K&N's: Health and Happiness for Pakistan, Teaching Note
Bell, David E.; McLoughlin, Damien P.; Shelman, MaryTeaching Note HBS-513077-EStrategyTeaching Note for 512002Starting at €0.00
-
Pakistan: Is Foreign Aid Helping or Hindering Development
Musacchio, Aldo; Chu, Ada; Nawabi, Shahnawaz; Schlefer, Jonathan; Staykov, EmilCase HBS-712005-EEconomicsNo abstract available.Starting at €8.20
-
Teva Pharmaceutical Industries, Ltd., Teaching Note
Khanna, Tarun; Palepu, Krishna G.Teaching Note HBS-708419-EStrategyTeaching note to 707441.Starting at €0.00
-
Akhuwat: Fighting Poverty with Interest-Free Microfinance
Khan, Ussama Ahmad; Cavanagh, RichardCase HBS-KS1198-EFinanceThis case is about Akhuwat - one of the largest micro-finance organizations in Pakistan. The case presents Akhuwat's phenomenal growth from a small philanthropic experiment into one of most prominent micro-finance organizations in Pakistan. This case also discusses the part played in this growth by Amjad Saqib, co-founder and Executive Director of Akhuwat, his relationship with the government and his charismatic leadership style. Akhuwat's unique...Starting at €8.20
-
Seeking Skills, Finding Barriers: Vocational Training in Punjab (Sequel)
Khwaja, Asim; Datla, AnjaniCase HBS-KS1262-EEconomicsSupplement to case KS1261. In March 2012, a flagship vocational program in Punjab, Pakistan-the Punjab Skills Development Fund (PSDF)-hit a roadblock. After months of planning, a pilot phase of training courses was launched in four of Punjab's poorest districts. The classes filled up, but the researchers in charge of evaluating PSDF's programs were worried. Earlier research indicated that a large portion of the target population-including a large...Starting at €8.20